|
|
Volumn 1, Issue 1, 2000, Pages
|
|
Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BRIDGED COMPOUND;
DOCETAXEL;
DRUG DERIVATIVE;
PACLITAXEL;
TAXANE;
TAXOID;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
BREAST TUMOR;
CANCER STAGING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DISEASE COURSE;
DOSE RESPONSE;
DRUG ADMINISTRATION;
EVIDENCE BASED MEDICINE;
FEMALE;
GENETICS;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MORTALITY;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PROTO ONCOGENE;
PSYCHOLOGICAL ASPECT;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SURVIVAL;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BREAST NEOPLASMS;
BRIDGED COMPOUNDS;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
DISEASE PROGRESSION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
EVIDENCE-BASED MEDICINE;
FEMALE;
GENES, ERBB-2;
HUMANS;
INFUSIONS, INTRAVENOUS;
NEOADJUVANT THERAPY;
NEOPLASM STAGING;
PACLITAXEL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL ANALYSIS;
TAXOIDS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
|
EID: 0034175066
PISSN: 15268209
EISSN: None
Source Type: Journal
DOI: 10.3816/cbc.2000.n.002 Document Type: Review |
|
Times cited : (87)
|
|
References (26)
|
